- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02247791
Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty (CHANCE)
January 27, 2016 updated by: Olof Skoldenberg, Danderyd Hospital
Study of Prosthesis Choice in Older Patients With a Dislocated Femoral Neck Fracture of the Hip
The purpose of this study is to evaluate whether an uncemented hip prosthesis is as safe as an cemented hip prosthesis for patients undergoing total hip arthroplasty surgery following a displaced femoral neck fracture.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will randomize patients between an uncemented and cemented stem
Study Type
Interventional
Enrollment (Anticipated)
140
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden, 18288
- Danderyd Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 79 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Acute Displaced femoral neck fracture
- Subject is aged between 65-79 years
- Independent walker with or without walking aides
- Subject is able and capable of providing consent to participate in the study
Exclusion Criteria:
- Patients with Rheumatoid Arthritis
- Patients with an impaired cognitive dysfunction
- Patients with Pathological fractures
- Patients with substance abuse
- Patients with fracture older than 36-hours on arrival at the A&E
- Patients suffering from cancer
- Patients determined by principal investigator to be unsuitable for inclusion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Cemented femoral stem
Patient undergoing total hip arthroplasty surgery
|
All patients will be randomized to operation with either an uncemented femoral stem or a cemented femoral stem
Other Names:
|
Active Comparator: Uncemented femoral stem
Patients undergoing total hip arthroplasty
|
All patients will be randomized to operation with either an uncemented femoral stem or a cemented femoral stem
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip related complication rate
Time Frame: 2 years
|
All hip-related complications
|
2 years
|
Health-related Quality of Life
Time Frame: 2 years
|
Health related quality of life
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of surgery
Time Frame: 2 years
|
2 years
|
|
Intraoperative bleeding
Time Frame: 2 years
|
2 years
|
|
Hip function
Time Frame: 2 years
|
Measured with Harris hip score
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ghazi Chammout, MD, Dept of Orthopaedics, Danderyd Hospital, Stockholm, Sweden
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Anticipated)
September 1, 2016
Study Completion (Anticipated)
September 1, 2024
Study Registration Dates
First Submitted
October 21, 2013
First Submitted That Met QC Criteria
September 23, 2014
First Posted (Estimate)
September 25, 2014
Study Record Updates
Last Update Posted (Estimate)
January 28, 2016
Last Update Submitted That Met QC Criteria
January 27, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHANCE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Smith & Nephew, Inc.Terminated
-
Texas Tech University Health Sciences Center, El...CompletedHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)United States
-
Carilion ClinicCompleted
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
Bayside HealthCompleted
-
University of Missouri-ColumbiaUniversity of Alabama at Birmingham; Medical College of Wisconsin; University...CompletedHip Fractures | Pelvic Fractures | Acetabular FracturesUnited States
-
Rabin Medical CenterUnknown
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
Clinical Trials on Cemented femoral stem
-
Qinghai UniversityUnknown
-
Northern Orthopaedic Division, DenmarkCompleted
-
Ain Shams UniversityCompletedLength of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic LesionArthroplasty | Metastatic Bone Tumor | Pathological FractureEgypt
-
Fowler Kennedy Sport Medicine ClinicZimmer BiometCompleted
-
Nova Scotia Health AuthorityCompleted
-
Stockholm South General HospitalKarolinska InstitutetUnknown
-
Peterborough and Stamford Hospitals NHS Foundation...Completed
-
Association pour le Développement et l'Enseignement...RecruitingOsteoarthritis, HipFrance
-
CorinRecruitingHip Fractures | Osteoarthritis, Hip | Femoral Neck Fractures | Avascular Necrosis of Hip | Hip HemiarthroplastyFrance
-
Medacta International SARecruitingArthrosis | Congenital Hip Dysplasia | Traumatic Arthritis | Rheumatoid Polyarthritis | Avascular Necrosis of the Femoral HeadAustria, Italy, Switzerland, United Kingdom